Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Gisbert

Showing results (201-210 of 211) with videos related to

Pageof 22
Sort By:
Alimentary Pharmacology & Therapeutics|July 5, 2011
Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patientsY González-Lama, F Bermejo, A López-Sanromán, et al.
Journal of Crohn'S & Colitis|April 13, 2019
Effectiveness and Safety of the Switch from Remicade® to CT-P13 in Patients with Inflammatory Bowel DiseaseM Chaparro, A Garre, M F Guerra Veloz, et al.
Alimentary Pharmacology & Therapeutics|January 26, 2018
Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control studyM Mañosa, M Calafat, R de Francisco, et al.
Journal of Crohn'S & Colitis|February 6, 2019
Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre StudyC Chavarría, M J Casanova, M Chaparro, et al.
Terapevticheskii Arkhiv|June 30, 2020
[European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years]D S Bordin, Y V Embutnieks, L G Vologzhanina, et al.
Terapevticheskii Arkhiv|February 1, 2019
European Registry on the management of Helicobacter pylori infection (Hp-EuReg): analysis of 2360 patients receiving first-line therapy in RussiaD S Bordin, Yu V Embutnieks, L G Vologzhanina, et al.
United European Gastroenterology Journal|April 30, 2026
Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida RegistryM Iborra, B Botella, M D Martín-Arranz, et al.
Alimentary Pharmacology & Therapeutics|March 12, 2026
Post-Operative Recurrence of Colonic Crohn's Disease After Colectomy: The RESECOL Study by the Young Group of GETECCUJ L Rueda García, C Suárez Ferrer, I García de la Filia Molina, et al.
Helicobacter|October 15, 2025
Empirical Rescue Eradication Therapy for Helicobacter pylori Infection in Second and Subsequent Treatment Lines: Experience From 500 Cases of the Brazilian Registry on H. pylori Management (Hp-BrazilReg)B S F Sanches, O P Nyssen, S R Chaves, et al.
The American Journal of Gastroenterology|February 21, 2018
Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY StudyM Chaparro, A Verreth, T Lobaton, et al.
Pageof 22

Showing results (201-210 of 211) with videos related to

Sort By:
Pageof 22
Alimentary Pharmacology & Therapeutics|July 5, 2011
Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patientsY González-Lama, F Bermejo, A López-Sanromán, et al.
Journal of Crohn'S & Colitis|April 13, 2019
Effectiveness and Safety of the Switch from Remicade® to CT-P13 in Patients with Inflammatory Bowel DiseaseM Chaparro, A Garre, M F Guerra Veloz, et al.
Alimentary Pharmacology & Therapeutics|January 26, 2018
Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control studyM Mañosa, M Calafat, R de Francisco, et al.
Journal of Crohn'S & Colitis|February 6, 2019
Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre StudyC Chavarría, M J Casanova, M Chaparro, et al.
Terapevticheskii Arkhiv|June 30, 2020
[European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years]D S Bordin, Y V Embutnieks, L G Vologzhanina, et al.
Terapevticheskii Arkhiv|February 1, 2019
European Registry on the management of Helicobacter pylori infection (Hp-EuReg): analysis of 2360 patients receiving first-line therapy in RussiaD S Bordin, Yu V Embutnieks, L G Vologzhanina, et al.
United European Gastroenterology Journal|April 30, 2026
Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida RegistryM Iborra, B Botella, M D Martín-Arranz, et al.
Alimentary Pharmacology & Therapeutics|March 12, 2026
Post-Operative Recurrence of Colonic Crohn's Disease After Colectomy: The RESECOL Study by the Young Group of GETECCUJ L Rueda García, C Suárez Ferrer, I García de la Filia Molina, et al.
Helicobacter|October 15, 2025
Empirical Rescue Eradication Therapy for Helicobacter pylori Infection in Second and Subsequent Treatment Lines: Experience From 500 Cases of the Brazilian Registry on H. pylori Management (Hp-BrazilReg)B S F Sanches, O P Nyssen, S R Chaves, et al.
The American Journal of Gastroenterology|February 21, 2018
Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY StudyM Chaparro, A Verreth, T Lobaton, et al.
Pageof 22